ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $166,579 | -18.8% | 30,565 | 0.0% | 0.02% | -11.1% |
| Q2 2023 | $205,091 | -24.2% | 30,565 | -0.3% | 0.02% | -30.8% |
| Q1 2023 | $270,640 | +15.6% | 30,650 | 0.0% | 0.03% | +13.0% |
| Q4 2022 | $234,166 | +7.4% | 30,650 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $218,000 | -50.2% | 30,650 | -43.3% | 0.02% | -45.2% |
| Q2 2022 | $438,000 | +8.7% | 54,100 | +86.6% | 0.04% | +31.2% |
| Q1 2022 | $403,000 | -48.7% | 29,000 | +3.6% | 0.03% | -47.5% |
| Q4 2021 | $786,000 | -17.4% | 28,000 | 0.0% | 0.06% | -23.8% |
| Q3 2021 | $952,000 | -16.8% | 28,000 | 0.0% | 0.08% | -12.1% |
| Q2 2021 | $1,144,000 | +1.5% | 28,000 | 0.0% | 0.09% | -6.2% |
| Q1 2021 | $1,127,000 | -31.9% | 28,000 | 0.0% | 0.10% | -38.6% |
| Q4 2020 | $1,656,000 | +21.6% | 28,000 | 0.0% | 0.16% | +11.3% |
| Q3 2020 | $1,362,000 | +0.5% | 28,000 | 0.0% | 0.14% | -7.8% |
| Q2 2020 | $1,355,000 | – | 28,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |